RockyP
Member
Any idea why Tren produces reduced cardio Capacity in humans?It seems we're of the same mind in terms of gear philosophy.
I was planning on running a Tren + E2 Cyp only blast and posting here.
If you look at the evidence behind it, it makes a lot of sense.
There are multiple papers showing that Tren is cardioprotective and suggesting it as an alternative to TRT due to reduced androgenic activity.
(Doses used were 2mg/kg, human-equivalent roughly = 0.325mg/kg. Something like 30-35mg/day (210-245mg/wk) for a 90-110kg person)
Research Evidence:
17β-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate
Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats
- Trenbolone decreased fat mass by 37% and increased lean mass by 11%
- No evidence of adverse cardiac (e.g., no fibrosis or impaired ischemia tolerance) or hepatic effects
Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome
- Reduced subcutaneous and visceral fat accumulation, hypertriglyceridemia, hypercholesterolemia, hyperinsulinemia, and myocardial damage compared to untreated deficient rats
- Improved myocardial tolerance to ischemia-reperfusion injury, suggesting cardioprotective effects
- Metabolic benefits included better insulin sensitivity and lipid profiles
